Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Eichstaedt, CA; Olschewski, A; Harbaum, L; Cordes, S; Dorfmüller, P; Foris, V; Kuebler, WM; Kwapiszewska, G; Pullamsetti, S; Sommer, N; Tabeling, C; Weissmann, N; Zoll, A; Hinderhofer, K; Schermuly, RT.
[Pathobiology and Genetics].
Pneumologie. 2025; 79(10):701-711
Doi: 10.1055/a-2625-4648
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Foris Vasile
-
Kwapiszewska-Marsh Grazyna
-
Olschewski Andrea
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Genetics and pathobiology were addressed at the 7th World Symposium on Pulmonary Hypertension in Task Forces 2 and 3. The Genetics Task Force also focused on precision medicine approaches, and the Pathobiology working group concentrated heavily on new omics technologies. Therefore, the following not only summarises the current state of knowledge on genetics, genetic testing methods, and molecular pathophysiological changes, but also places it in context and critically discusses it. In addition, the importance of national and international biobanks and cohorts, as well as the active involvement of patients and families, is emphasized.
- Find related publications in this database (using NLM MeSH Indexing)
-
Humans - administration & dosage
-
Hypertension, Pulmonary - genetics, pathology, diagnosis
-
Genetic Testing - methods, trends
-
Genetic Predisposition to Disease - genetics
-
Precision Medicine - trends